Skip to content

Portal | Investors | KOR

GC Genome
  • Product

    Product

    Empowering Personalized healthcare through Genetic Insights

    • How to Order
    • Test Catalogue
    • Pre&Neonatal Health
      • G-NIPT
      • i-screen
    • Health Checkup
      • Genome Health
      • Genome Screen
      • Greenbiome GUT
      • Pharmacogenetic Test
      • Telorisk
    • Precision Oncology
      • Women’s Cancer Panel
      • Hereditary Cancer Panel
      • Solid Tumor Cancer Panel
      • Hematology Cancer Panel
      • Liquid Biopsy
      • HRD
    • Rare Disease
      • DES/WES/DGS
      • CMA
      • SMN1/2
  • Our science

    Our science

    Our Science endlessly advancing to Empower Care and Inspire Cure

    • Our Approach
    • Technologies
    • Focused Areas
      • Liquid Biopsy(MCED)
      • NIPT
      • HRD
      • Microbiome
    • Pipeline
    • Government Project
  • Resource

    Resource

    Explore Insights from GC Genome

    • Publications
    • Blog
    • Certificate
    • Download
  • Company

    Company

    Our dedication to connect the care and cure to the world

    • Company Overview
    • About us
    • Press Release
    • Global Partners
    • Contact us
GC Genome
  • Product
    • Pre&Neonatal Health
      • G-NIPT
      • i-screen
    • Health Checkup
      • Genome Health
      • Genome Screen
      • Greenbiome GUT
      • Pharmacogenetic Test
      • Telorisk
    • Precision Oncology
      • Women’s Cancer Panel
      • Hereditary Cancer Panel
      • Solid Tumor Cancer Panel
      • Hematology Cancer Panel
      • Liquid Biopsy
      • HRD
    • Rare Disease
      • DES/WES/DGS
      • CMA
      • SMN1/2
  • Our science
    • Our Approach
    • Technologies
    • Focused Areas
      • Liquid Biopsy(MCED)
      • NIPT
      • HRD
      • Microbiome
    • Pipeline
    • Government Project
  • Resource
    • Publications
    • Blog
    • Certificate
    • Download
  • Company
    • Company Overview
    • About us
    • History of us
    • Press Release
    • Global Partners
    • Contact us

Hematologic Cancer Panel_Lymphoma
Sample Report

epart2023-09-15T13:32:44+09:00September 7, 2023|

About the Author: epart

Product

  • Pre&Neonatal Health
  • Health Checkup
  • Precesion Oncology
  • Rare disease
  • Test Catalogue

Our Science

  • Our Approach
  • Technologies
  • Focused Areas
  • Pipeline
  • Government Project

Resource

  • Publications
  • Blog
  • Certificate
  • Download

Company

  • Company Overview
  • About us
  • History of us
  • Press Release
  • Global Partners
  • Contact us
  • Privacy Policy
  • Terms of Use
  • GC Family Site

GC Family Site

Pharmaceutical

  • GC Biopharma
  • GC Cell

Healthcare

  • GC Wellbeing
  • GC Care
  • UBcare
  • Able Analytics

Diagnosis

  • GCMS
  • GC Medis
  • GCCL
  • Green Vet
  • Genes Laboratories

Overseas

  • GC China
  • GC China Pharm
  • GC LabTech
  • GC Biopharma USA
  • Curevo
  • GC Lymphotech
  • GC Biopharma do Brasil
  • Ativa Biotherapeutics, Inc.
  • BioCentriq

Foundation

  • MOGAM Institute for Biomedical Research
  • Mogam Science Scholarship Foundation
  • Future Foundation of Korea
  • GC Labs
  • GC I-MED

Moreover

  • GCEM
  • GC Invacfarm
  • Privacy Policy
  • Terms of Use
  • GC Family Site
GC Genome

GC Genome Corporation I Representative: KI CHANG SEOK I Business Registration No. 142-81-61687
107, Ihyeon-ro 30beon-gil, Giheung-gu, Yongin-si, Gyeonggi-do, 16924, Korea
Email. info@gcgenome.com I Tel. +82 31-280-9939 I Fax. +82 31-260-9087 ©2023 by GC Genome.

Page load link
Go to Top